Brain imaging is one of several diagnostic tools used to help detect and monitor Alzheimer’s disease and other types of dementia. These advanced imaging techniques help specialists see changes in brain structure and function, such as amyloid plaque and tau tangle buildup, and patterns of brain cell loss.
Imaging also helps identify other potentially treatable brain conditions, such as tumors or blood vessel changes, that might contribute to memory loss or thinking problems.
At Banner Alzheimer’s Institute - a designated Memory Care Center of Excellence by the National Institutes of Health - specialists are world leaders in developing, validating and using advanced brain imaging to diagnose and study Alzheimer’s disease and related conditions.
In a clinical setting, brain imaging assists your doctor in:
In a research setting, brain imaging is helping scientists:
Your doctor will discuss which imaging test best fits your needs. The most common scans include MRI and PET scans.
MRI uses powerful magnets to create detailed images of the brain. Banner Health uses advanced 3 Tesla (3T) MRI technology, which produces exceptionally detailed brain images.
MRI can help identify:
PET scans use a tiny amount of a safe, radioactive tracer injected through an IV to show how the brain is working. The exposure is minimal and short-term.
PET imaging helps visualize:
FDG PET measures how the brain uses glucose - its main energy source - to reveal patterns of reduced metabolism related to brain cell loss.
Banner research has shown how FDG PET can:
Clinicians can compare a person’s results with typical patterns of Alzheimer’s, frontotemporal dementia or other conditions to clarify diagnosis.
Amyloid PET scans show amyloid plaque buildup, one of the brain changes required to diagnose Alzheimer’s disease.
Banner researchers helped lead national efforts that made this technology widely available. Their work demonstrated how amyloid PET can:
Tau PET scans measure the accumulation of tau tangles, the other key brain abnormality in Alzheimer’s disease.
Banner researchers have:
Although tau PET is less commonly used or reimbursed than amyloid PET, it can:
Tau PET is most often used in research and clinical trials to better understand how tau buildup relates to Alzheimer’s progression.
The experts at Banner Alzheimer’s Institute are deeply involved in both clinical and research applications of brain imaging. Their work is helping patients receive the most complete and accurate diagnostic testing available today while driving innovations that will shape tomorrow’s Alzheimer’s care.
If you’ve noticed changes in your memory or thinking - or in a loved one - don’t wait. Schedule an appointment with a Banner Health specialist to discuss testing and next steps.